dc.creatorYaribeygi H.
dc.creatorButler A.E.
dc.creatorBarreto G.E.
dc.creatorSahebkar A.
dc.date.accessioned2020-09-02T22:30:36Z
dc.date.accessioned2022-11-08T20:17:50Z
dc.date.available2020-09-02T22:30:36Z
dc.date.available2022-11-08T20:17:50Z
dc.date.created2020-09-02T22:30:36Z
dc.date.issued2019
dc.identifier234, 3, 2436-2446
dc.identifier00219541
dc.identifierhttps://hdl.handle.net/20.500.12728/6643
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5142466
dc.languageen
dc.publisherWiley-Liss Inc.
dc.subjectantidiabetic medications
dc.subjectdiabetes
dc.subjectdiabetic nephropathy (DN)
dc.subjectoxidative stress
dc.subjectvascular dysfunction
dc.subject2,4 thiazolidinedione derivative
dc.subjectantidiabetic agent
dc.subjectbiguanide derivative
dc.subjectdipeptidyl peptidase IV inhibitor
dc.subjectglucagon like peptide 1 receptor agonist
dc.subjectinsulin
dc.subjectsodium glucose cotransporter 2 inhibitor
dc.subjectsulfonylurea derivative
dc.subjectantidiabetic agent
dc.subjectantioxidant
dc.subjectantioxidant activity
dc.subjectdiabetic complication
dc.subjectdiabetic patient
dc.subjectdrug mechanism
dc.subjecthuman
dc.subjectnonhuman
dc.subjectoxidative stress
dc.subjectpriority journal
dc.subjectReview
dc.subjectvascular disease
dc.subjectcardiovascular disease
dc.subjectdiabetes mellitus
dc.subjectdiabetic angiopathy
dc.subjectdrug effect
dc.subjectglucose blood level
dc.subjectmetabolism
dc.subjectpathology
dc.subjectquality of life
dc.subjectAntioxidants
dc.subjectBlood Glucose
dc.subjectCardiovascular Diseases
dc.subjectDiabetes Mellitus
dc.subjectDiabetic Angiopathies
dc.subjectHumans
dc.subjectHypoglycemic Agents
dc.subjectOxidative Stress
dc.subjectQuality of Life
dc.titleAntioxidative potential of antidiabetic agents: A possible protective mechanism against vascular complications in diabetic patients
dc.typeReview


Este ítem pertenece a la siguiente institución